KOPRAN
Back to Cashflow Statement
|
KOPRAN Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹0.99 Cr | ₹-20 Cr | ₹123 Cr | ₹-35 Cr | ₹-18 Cr |
What is the latest Cash Flow from Financing Activities ratio of KOPRAN ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹0.99 Cr |
Mar2023 | ₹-20 Cr |
Mar2022 | ₹123 Cr |
Mar2021 | ₹-35 Cr |
Mar2020 | ₹-18 Cr |
How is Cash Flow from Financing Activities of KOPRAN Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹0.99 Cr | Positive | |
Mar2023 | ₹-20 Cr | Negative | |
Mar2022 | ₹123 Cr | Positive | |
Mar2021 | ₹-35 Cr | Negative | |
Mar2020 | ₹-18 Cr | - |
Compare Cash Flow from Financing Activities of peers of KOPRAN
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KOPRAN | ₹1,413.7 Cr | -8.4% | -1.4% | 34.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹431,844.0 Cr | -1.5% | -5.7% | 52.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹154,155.0 Cr | -2.2% | -6.5% | 68.5% | Stock Analytics | |
CIPLA | ₹123,138.0 Cr | -4.4% | -4.7% | 25.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,391.0 Cr | -3.1% | -5.2% | 18.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,602.3 Cr | -4.5% | -10.6% | 58.1% | Stock Analytics |
KOPRAN Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KOPRAN | -8.4% |
-1.4% |
34.6% |
SENSEX | -1% |
-3.3% |
21.1% |
You may also like the below Video Courses